Additionally, we found that sorafenib effectively increased apoptosis markers (TUNEL) and inhibited the angiogenesis markers (CD31) besides causing ferroptosis in CRC (Figure 8P; Figure S7D, Supporting Information). This evidence concerns the gene PECAM1 and colorectal carcinoma.